FDA Approved: DEFERASOROX — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

The FDA granted approval for the original ANDA application of Deferasorox (deferasirox) by Novadoz Pharmaceuticals LLC as a generic product. It is intended for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Beta Thalassemia Major
• Iron Overload
• Myelodysplastic Syndrome
• Transfusion-dependent Anemia

Drugs mentioned

• DEFERASOROX (DEFERASIROX)

Snippet

ORIG AP for DEFERASOROX (DEFERASIROX)